Atlas Trials

Study to Assess Tolerability of Injecting Larger Volumes (2-5 mL) Subcutaneously at Different Rates: Participant Experience and Acceptance

Clinical trial NCT07769489 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07769489
Sponsor
Novo Nordisk A/S
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Participants
Start date
2026-08-17
Primary completion
2026-12-09
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.